Howland Capital Management LLC Sells 349 Shares of Danaher Corporation (DHR)
Howland Capital Management LLC cut its stake in shares of Danaher Corporation (NYSE:DHR) by 0.1% during the second quarter, according to its most recent filing with the SEC. The firm owned 247,099 shares of the conglomerate’s stock after selling 349 shares during the period. Danaher Corporation accounts for approximately 1.8% of Howland Capital Management LLC’s investment portfolio, making the stock its 19th largest position. Howland Capital Management LLC’s holdings in Danaher Corporation were worth $20,853,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of DHR. Hudson Valley Investment Advisors Inc. ADV purchased a new position in Danaher Corporation during the first quarter valued at about $567,000. Douglas Lane & Associates LLC boosted its position in Danaher Corporation by 1.8% in the first quarter. Douglas Lane & Associates LLC now owns 555,791 shares of the conglomerate’s stock valued at $47,537,000 after buying an additional 9,684 shares in the last quarter. Motco boosted its position in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock valued at $158,000 after buying an additional 390 shares in the last quarter. State of Alaska Department of Revenue boosted its position in Danaher Corporation by 41.4% in the first quarter. State of Alaska Department of Revenue now owns 17,278 shares of the conglomerate’s stock valued at $1,476,000 after buying an additional 5,058 shares in the last quarter. Finally, Oakbrook Investments LLC purchased a new position in Danaher Corporation during the first quarter valued at about $4,644,000. Institutional investors and hedge funds own 76.12% of the company’s stock.
Danaher Corporation (NYSE DHR) traded up 1.26% during midday trading on Tuesday, hitting $82.10. The stock had a trading volume of 868,643 shares. The company’s 50 day moving average price is $82.22 and its 200-day moving average price is $84.21. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.01. The stock has a market capitalization of $57.03 billion, a price-to-earnings ratio of 26.20 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. The company had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. Danaher Corporation’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.90 earnings per share. Equities analysts anticipate that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This article was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.thecerbatgem.com/2017/08/22/howland-capital-management-llc-sells-349-shares-of-danaher-corporation-dhr.html.
Several research firms recently issued reports on DHR. Janney Montgomery Scott cut Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, June 21st. Deutsche Bank AG reiterated a “buy” rating and issued a $97.00 price target on shares of Danaher Corporation in a report on Wednesday, June 21st. Zacks Investment Research cut Danaher Corporation from a “hold” rating to a “sell” rating in a report on Monday, June 19th. Finally, Credit Suisse Group reiterated a “buy” rating and issued a $93.00 price target on shares of Danaher Corporation in a report on Wednesday, May 24th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $91.76.
In other news, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the transaction, the director now directly owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the transaction, the insider now directly owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 27,808 shares of company stock valued at $2,296,236. 12.20% of the stock is currently owned by corporate insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.